Anticancer Activity of Continentalic Acid in B-Cell Lymphoma

<i>Aralia continentalis</i> has been used in Korea as a folk remedy for arthralgia, rheumatism, and inflammation. However, its anti-lymphoma effect remains uncharacterized. Here, we demonstrate that <i>A. continentalis</i> extract and its three diterpenes efficiently kill B-l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Byeol-Eun Jeon, Chan-Seong Kwon, Ji-Eun Lee, Keumok Moon, Jaeho Cha, Inmyoung Park, Sara Koh, Myunghee Yoon, Sang-Woo Kim, Jeong Nam Kim
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/b3acb427821249b785f9eae5382abf53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b3acb427821249b785f9eae5382abf53
record_format dspace
spelling oai:doaj.org-article:b3acb427821249b785f9eae5382abf532021-11-25T18:27:41ZAnticancer Activity of Continentalic Acid in B-Cell Lymphoma10.3390/molecules262268451420-3049https://doaj.org/article/b3acb427821249b785f9eae5382abf532021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/22/6845https://doaj.org/toc/1420-3049<i>Aralia continentalis</i> has been used in Korea as a folk remedy for arthralgia, rheumatism, and inflammation. However, its anti-lymphoma effect remains uncharacterized. Here, we demonstrate that <i>A. continentalis</i> extract and its three diterpenes efficiently kill B-lymphoma cells. Our in vitro and in vivo results suggest that the cytotoxic activities of continentalic acid, a major diterpene from <i>A. continentalis</i> extract, are specific towards cancer cells while leaving normal murine cells and tissues unharmed. Mechanistically, continentalic acid represses the expression of pro-survival Bcl-2 family members, such as Mcl-1 and Bcl-xL. It dissociates the mitochondrial membrane potential, leading to the stimulation of effector caspase 3/7 activities and, ultimately, cell death. Intriguingly, this agent therapeutically synergizes with roflumilast, a pan-PDE4 inhibitor that has been successfully repurposed for the treatment of aggressive B-cell malignancies in recent clinical tests. Our findings unveiled that <i>A. continentalis</i> extract and three of the plant’s diterpenes exhibit anti-cancer activities. We also demonstrate the synergistic inhibitory effect of continentalic acid on the survival of B-lymphoma cells when combined with roflumilast. Taken in conjunction, continentalic acid may hold significant potential for the treatment of B-cell lymphoma.Byeol-Eun JeonChan-Seong KwonJi-Eun LeeKeumok MoonJaeho ChaInmyoung ParkSara KohMyunghee YoonSang-Woo KimJeong Nam KimMDPI AGarticle<i>Aralia continentalis</i>diterpenesB-cell lymphomaanti-cancer activitiesOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6845, p 6845 (2021)
institution DOAJ
collection DOAJ
language EN
topic <i>Aralia continentalis</i>
diterpenes
B-cell lymphoma
anti-cancer activities
Organic chemistry
QD241-441
spellingShingle <i>Aralia continentalis</i>
diterpenes
B-cell lymphoma
anti-cancer activities
Organic chemistry
QD241-441
Byeol-Eun Jeon
Chan-Seong Kwon
Ji-Eun Lee
Keumok Moon
Jaeho Cha
Inmyoung Park
Sara Koh
Myunghee Yoon
Sang-Woo Kim
Jeong Nam Kim
Anticancer Activity of Continentalic Acid in B-Cell Lymphoma
description <i>Aralia continentalis</i> has been used in Korea as a folk remedy for arthralgia, rheumatism, and inflammation. However, its anti-lymphoma effect remains uncharacterized. Here, we demonstrate that <i>A. continentalis</i> extract and its three diterpenes efficiently kill B-lymphoma cells. Our in vitro and in vivo results suggest that the cytotoxic activities of continentalic acid, a major diterpene from <i>A. continentalis</i> extract, are specific towards cancer cells while leaving normal murine cells and tissues unharmed. Mechanistically, continentalic acid represses the expression of pro-survival Bcl-2 family members, such as Mcl-1 and Bcl-xL. It dissociates the mitochondrial membrane potential, leading to the stimulation of effector caspase 3/7 activities and, ultimately, cell death. Intriguingly, this agent therapeutically synergizes with roflumilast, a pan-PDE4 inhibitor that has been successfully repurposed for the treatment of aggressive B-cell malignancies in recent clinical tests. Our findings unveiled that <i>A. continentalis</i> extract and three of the plant’s diterpenes exhibit anti-cancer activities. We also demonstrate the synergistic inhibitory effect of continentalic acid on the survival of B-lymphoma cells when combined with roflumilast. Taken in conjunction, continentalic acid may hold significant potential for the treatment of B-cell lymphoma.
format article
author Byeol-Eun Jeon
Chan-Seong Kwon
Ji-Eun Lee
Keumok Moon
Jaeho Cha
Inmyoung Park
Sara Koh
Myunghee Yoon
Sang-Woo Kim
Jeong Nam Kim
author_facet Byeol-Eun Jeon
Chan-Seong Kwon
Ji-Eun Lee
Keumok Moon
Jaeho Cha
Inmyoung Park
Sara Koh
Myunghee Yoon
Sang-Woo Kim
Jeong Nam Kim
author_sort Byeol-Eun Jeon
title Anticancer Activity of Continentalic Acid in B-Cell Lymphoma
title_short Anticancer Activity of Continentalic Acid in B-Cell Lymphoma
title_full Anticancer Activity of Continentalic Acid in B-Cell Lymphoma
title_fullStr Anticancer Activity of Continentalic Acid in B-Cell Lymphoma
title_full_unstemmed Anticancer Activity of Continentalic Acid in B-Cell Lymphoma
title_sort anticancer activity of continentalic acid in b-cell lymphoma
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/b3acb427821249b785f9eae5382abf53
work_keys_str_mv AT byeoleunjeon anticanceractivityofcontinentalicacidinbcelllymphoma
AT chanseongkwon anticanceractivityofcontinentalicacidinbcelllymphoma
AT jieunlee anticanceractivityofcontinentalicacidinbcelllymphoma
AT keumokmoon anticanceractivityofcontinentalicacidinbcelllymphoma
AT jaehocha anticanceractivityofcontinentalicacidinbcelllymphoma
AT inmyoungpark anticanceractivityofcontinentalicacidinbcelllymphoma
AT sarakoh anticanceractivityofcontinentalicacidinbcelllymphoma
AT myungheeyoon anticanceractivityofcontinentalicacidinbcelllymphoma
AT sangwookim anticanceractivityofcontinentalicacidinbcelllymphoma
AT jeongnamkim anticanceractivityofcontinentalicacidinbcelllymphoma
_version_ 1718411152840458240